Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. MEGACE (mégestrol (acétate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MEGACE (mégestrol (acétate de))

Medicine - Posted on Sep 20 2017 - Updated on Jun 12 2019
Active substance (DCI)
  • mégestrol (acétate de)
history (4)
  • 9/13/17

    MEGACE (mégestrol (acétate de))

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 9/18/13

    MEGACE (mégestrol (acétate de))

    MEGACE (mégestrol (acétate de))
    icône flèche
  • 9/22/10

    MEGACE (mégestrol (acétate de))

    MEGACE (mégestrol (acétate de))
    icône flèche
  • 9/7/05

    MEGACE 160 mg, comprimé - Boîte de 30 (CIP: 336 047-2)

    MEGACE 160 mg, comprimé - Boîte de 30 (CIP: 336 047-2)
    icône flèche
Technical information
ATC code
  • L02AB01
Manufacturer
SWEDISH ORPHAN BIOVITRUM
Presentation

MEGACE 160 mg, comprimé (code CIS : 67448384) plaquette(s) thermoformée(s) PVC aluminium de 30 comprimé(s) - Code CIP : 3400933604721

All our publications
    Breast cancers Drug therapy Palliative and terminal care

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
66YcKV7Nh3dm6vPM